http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019000822-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_258173b01dd980457214a5b7c2b8a301
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
filingDate 2016-02-24^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_573bfa9c15ab54c413b8c305043330b4
publicationDate 2019-01-03^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2019000822-A1
titleOfInvention Chlorine or bromine salts of cetylpyridinium for use in the treatment of cutaneous and acute porphyrias and psoriasis
abstract The present invention relates to chlorine or bromine salts of cetylpyridinium for use in the treatment of porphyrias and psoriasis, as well as methods of treatment of these diseases in human patients by using hydro-alcoholic solutions of cetylpyridinium chloride or bromide.
priorityDate 2016-02-24^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009304812-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006054312-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011027327-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7175850-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3511914-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011319805-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID379849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5481287
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2683
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID165
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID379849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31239
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID14
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226494072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406092
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396692
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2113

Showing number of triples: 1 to 56 of 56.